Product NDC: | 68258-3029 |
Proprietary Name: | Next Choice |
Non Proprietary Name: | levonorgestrel |
Active Ingredient(s): | .75 mg/1 & nbsp; levonorgestrel |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68258-3029 |
Labeler Name: | Dispensing Solutions, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078665 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090904 |
Package NDC: | 68258-3029-1 |
Package Description: | 1 BLISTER PACK in 1 CARTON (68258-3029-1) > 2 TABLET in 1 BLISTER PACK |
NDC Code | 68258-3029-1 |
Proprietary Name | Next Choice |
Package Description | 1 BLISTER PACK in 1 CARTON (68258-3029-1) > 2 TABLET in 1 BLISTER PACK |
Product NDC | 68258-3029 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levonorgestrel |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090904 |
Marketing Category Name | ANDA |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | LEVONORGESTREL |
Strength Number | .75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Inhibit Ovum Fertilization [PE],Progesterone Congeners [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC],Progestin-containing Intrauterine Device [EPC] |